**Core tip:** Selection of the appropriate endoscopic method for the removal of diminutive colorectal polyps (DCPs), according to the prospective prevention of colorectal cancer, is still a debatable topic. The new recommendation released by ESGE (European Society of Gastrointestinal Endoscopy, 2017) concerning the use of hot biopsy forceps (HBF) is expected to create a shift in daily clinical practice since this technique is still popular and viable for the removal of DCPs. In this letter, the authors request reconsideration of this policy in response to published data referring on the efficacy and safety of HBF and recommend a more cautious approach and transition to prevent the premature acceptance of alternative techniques.

TO THE EDITOR
=============

In a recent article\[[@B1]\], European Society of Gastrointestinal Endoscopy has released guidelines for colorectal polypectomy, which include a strong recommendation against the use of hot biopsy forceps (HBF) based on the GRADE system of clinical evidence. The release of guidelines by professional medical societies is acknowledged by the medical community as policy that functions as a deterrent to specific practices. With respect to that notion, the abandonment of a useful technique such HBF, which for many decades, has contributed to the polypectomy of diminutive colorectal polyps (DCPs), should be considered in an appropriate conscientious and judicious manner.

The reasons for the negative criticism are based on the following: (1) unacceptably high risks of adverse events (AEs); (2) inadequate tissue sampling for histopathology (ITSH); and (3) high incomplete resection rates (IRR). The studies cited in support of the recommendation are 4 human studies (1 RCT non-blinded with a small number of patients\[[@B2]\], one anecdotal report\[[@B3]\] and 2 observational studies\[[@B4],[@B5]\]), 3 of which have already been determined to be of low quality, and 2 animal studies\[[@B6],[@B7]\] (Table [1](#T1){ref-type="table"}). The overall quality of evidence was graded as high. Actually, apart from the methodological quality of the individual studies and the questionable generalizability, these studies are heterogeneous in terms of ITSH and IRR. Moreover, all studies are consistent with respect to the absence of perforations, and the few bleeding episodes (0.36%) in one of the studies occured in patients taking antiplatelets\[[@B5]\].

###### 

List of articles presented in support of European Society of Gastrointestinal Endoscopy guidelines

  **Ref**.                               **Study design**      **No of polyps and patients**                           **Level of evidence**
  -------------------------------------- --------------------- ------------------------------------------------------- ---------------------------
  Paspatis et al\[[@B2]\], 2005          Randomised trial      38 *vs* 37 rectal DCPs among 50 patients                High quality
  Bipolar electro-coagulation *vs* HBF                                                                                 
  Peluso et al\[[@B3]\], 1991            Anecdotal report      62 DCPs among 39 patients                               Low quality
  HBF                                                                                                                  
  Yasar *et a*l\[[@B4]\], 2015           Observational study   237 DCPs among 179 patients                             Low quality
  HBF *vs* JBF                                                                                                         
  Weston et al\[[@B5]\], 1995            Observational study   1964 DCPs among 687 patients                            Low quality
  HBF *vs* CBF                                                                                                         
  Savides et al\[[@B6]\], 1995           Animal study          231 biopsies in 16 right colotomies of 8 mongrel dogs   Not rated in Grade system
  Canine model                                                                                                         
  Metz et al\[[@B7]\], 2013              Animal study          82 artificial polyps, sized 5-8 mm                      Not rated in Grade system
  Porcine model                                                                                                        

JBF: Jumbo biopsy forceps; CBF: Cold biopsy forceps; DCPs: Diminutive colorectal polyps; HBF: Hot biopsy forceps.

HBF is considered an alternative method for the removal of DCPs (≤ 5 mm). According to different surveys, it seems that HBF is still a viable option that is preferred by 30%-50% of endoscopists\[[@B8]-[@B10]\]. The two studies, with the largest number of patients and polyps\[[@B11],[@B12]\] showed no complications. The study by Wadas et al\[[@B13]\], which reports a 0.38% major bleeding rate and a 0.05% perforation rate, refers to a questionnaire-type survey from an era (1988) when the HBF technique was not standardized. Even this perforation rate is lower than the reported 0.15% for therapeutic colonoscopies\[[@B14]\]. The rate of AEs is also lower compared with that for snare polypectomies (3.3 *vs* 4.5/1000), and AEs are more likely to occur when low- volume endoscopists use HBF than when high-volume endoscopists (\> 300 polypectomies/year) use the technique\[[@B15]\].

HBF has been reported to have a 17% IRR when white coagulum is present\[[@B16]\] and a variable rate of ITSH that ranges from 0.19%-13%-26.7% in studies with different mean polyp sizes\[[@B11],[@B17],[@B18]\]. It is acknowledged that a significant predictor of histological misinterpretation is decreasing polyp size with a cut off limit of 2 mm. It is important to mention that even in studies with high reported rates of cautery artifacts\[[@B4]\], the results showed that histological diagnosis could indeed have been reached in all specimens.

The new rival of HBF, namely, the cold snare polypectomy (CSP), has thus far presented disparate results for IRR at 3.4%-40%, retrieval failure at 1%-13%, and bleeding rates of 1.2%-20% for DCPs\[[@B19]-[@B24]\]. In the sole non-blinded RCT, in which HBF and CSP are directly compared, the IRR in the ITT analysis was 29.9% for CSP, which is still unacceptably high. However, the bleeding rates were statistically insignificant at 8.1% *vs* 8.8% for HBF and CSP, respectively, and no perforations were observed in either study arm\[[@B25]\].

In conclusion, it seems that available evidence is not adequate to exclude hot biopsy forceps from the routine endoscopy practice. We either need more prospective studies exhibiting beneficial comparisons with new techniques or we need to focus on proper utilization of HBF by more experienced endoscopists.
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